Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RARE - Ultragenyx Pharmaceutical's price target lowered by Cowen analyst rating maintained

RARE - Ultragenyx Pharmaceutical's price target lowered by Cowen analyst rating maintained

Ultragenyx Pharmaceutical Inc.
Cowen analyst Yaron Werber lowered Ultragenyx Pharmaceutical's (NASDAQ:RARE) price target to $99 from $124 after Q1 results. The Outperform rating on the shares were maintained. RARE's Q1 GAAP EPS of -$2.19 misses by $0.41, revenue of $79.9M misses by $4.35M.

For further details see:

Ultragenyx Pharmaceutical's price target lowered by Cowen analyst, rating maintained
Stock Information
Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com
Menu
RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...